Follow
Maryam Nazemipour
Maryam Nazemipour
Verified email at razi.tums.ac.ir
Title
Cited by
Cited by
Year
A checklist for statistical assessment of medical papers (the CHAMP statement): explanation and elaboration
MA Mansournia, GS Collins, RO Nielsen, M Nazemipour, NP Jewell, ...
British journal of sports medicine 55 (18), 1009-1017, 2021
1422021
Reflection on modern methods: demystifying robust standard errors for epidemiologists
MA Mansournia, M Nazemipour, AI Naimi, GS Collins, MJ Campbell
International Journal of Epidemiology 50 (1), 346-351, 2021
1412021
Seroprevalence of SARS-CoV-2 in guilan province, Iran, April 2020
M Shakiba, M Nazemipour, A Salari, F Mehrabian, SSH Nazari, ...
Emerging infectious diseases 27 (2), 636, 2021
742021
Update on SARS-CoV-2 seroprevalence: regional and worldwide
A Rostami, M Sepidarkish, A Fazlzadeh, AH Mokdad, A Sattarnezhad, ...
Clinical Microbiology and Infection 27 (12), 1762-1771, 2021
602021
To adjust or not to adjust: the role of different covariates in cardiovascular observational studies
M Etminan, JM Brophy, G Collins, M Nazemipour, MA Mansournia
American Heart Journal 237, 62-67, 2021
482021
Bland-Altman methods for comparing methods of measurement and response to criticisms
MA Mansournia, R Waters, M Nazemipour, M Bland, DG Altman
Global Epidemiology 3, 100045, 2021
402021
Prevalence of asymptomatic COVID-19 infection using a seroepidemiological survey
M Shakiba, M Nazemipour, A Heidarzadeh, MA Mansournia
Epidemiology & Infection 148, e300, 2020
362020
Causal diagrams for immortal time bias
MA Mansournia, M Nazemipour, M Etminan
International journal of epidemiology 50 (5), 1405-1409, 2021
342021
Potential biases in studies of acid-suppressing drugs and COVID-19 infection
M Etminan, M Nazemipour, MA Mansournia
Gastroenterology 160 (5), 1443-1446, 2021
342021
P-value, compatibility, and S-value
MA Mansournia, M Nazemipour, M Etminan
Global epidemiology 4, 100085, 2022
302022
Risk factors of developing critical conditions in Iranian patients with COVID-19
A Arman, M Tajik, M Nazemipour, Z Ahmadinejad, SK Shahrestanaki, ...
Global epidemiology 3, 100046, 2021
202021
A practical guide to handling competing events in etiologic time-to-event studies
MA Mansournia, M Nazemipour, M Etminan
Global Epidemiology 4, 100080, 2022
192022
The causal effect and impact of reproductive factors on breast cancer using super learner and targeted maximum likelihood estimation: a case-control study in Fars Province, Iran
A Almasi-Hashiani, S Nedjat, R Ghiasvand, S Safiri, M Nazemipour, ...
BMC Public Health 21 (1), 1219, 2021
192021
Population attributable fraction in textbooks: time to revise
A Khosravi, M Nazemipour, T Shinozaki, MA Mansournia
Global Epidemiology 3, 100062, 2021
182021
Effect of smoking on breast cancer by adjusting for smoking misclassification bias and confounders using a probabilistic bias analysis method
R Pakzad, S Nedjat, M Yaseri, H Salehiniya, N Mansournia, ...
Clinical epidemiology, 557-568, 2020
172020
Estimating the marginal causal effect and potential impact of waterpipe smoking on risk of multiple sclerosis using the targeted maximum likelihood estimation method: a large …
I Abdollahpour, S Nedjat, A Almasi-Hashiani, M Nazemipour, ...
American journal of epidemiology 190 (7), 1332-1340, 2021
152021
Interaction contrasts and collider bias
MA Mansournia, M Nazemipour, M Etminan
American Journal of Epidemiology 191 (10), 1813-1819, 2022
142022
Time-fixed vs time-varying causal diagrams for immortal time bias
MA Mansournia, M Nazemipour, M Etminan
International journal of epidemiology 51 (3), 1030-1031, 2022
122022
The effects of smoking on metabolic syndrome and its components using causal methods in the Iranian population
F Khodamoradi, M Nazemipour, N Mansournia, K Yazdani, D Khalili, ...
International Journal of Preventive Medicine 12 (1), 118, 2021
112021
Challenges for management of the COVID-19 epidemic in Iran
A Doosti-Irani, E Mostafavi, M Nazemipour, MA Mansournia, ...
Global epidemiology 2, 100035, 2020
112020
The system can't perform the operation now. Try again later.
Articles 1–20